The Impact of Race on the Efficacy of Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions

被引：0
|
作者：
Osathanugrah, Pawarissara [1 ]
Prasad, Minali [1 ]
Sanjiv, Nayan [1 ]
Ness, Steven [1 ]
Siegel, Nicole H. [1 ]
Chen, Xuejing [1 ]
Subramanian, Manju L. [1 ]
机构：
[1] Boston Med Ctr, Ophthalmol, Boston, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1760
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Recurrence of macular edema after intravitreal bevacizumab injection in eyes with macular edema secondary to retinal vein occlusion
    Kim, Young Gyun
    Moon, Ji Young
    Seo, Kyung Hoon
    Lee, Seung Yong
    Kim, Eung Suk
    Yu, Seung Young
    Kwak, Hyung Woo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [22] Impact of Early Anatomical and Functional Responses to Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion
    Noh, Donghyoun
    Ryu, Gahyung
    Lee, Junyeop
    Sagong, Min
    OPHTHALMOLOGICA, 2018, 239 (04) : 194 - 204
  • [23] Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusions in Patients with Previous Uneffective Treatments
    Esposito, Fernando
    Chandran, Manju
    Menon, Geeta
    OPHTHALMOLOGICA, 2014, 232 : 93 - 93
  • [24] Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
    Hirose, Miki
    Matsumiya, Wataru
    Honda, Shigeru
    Nakamura, Makoto
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 2301 - 2305
  • [25] REBOUND OF MACULAR EDEMA AFTER INTRAVITREAL BEVACIZUMAB THERAPY IN EYES WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION
    Yasuda, Shunsuke
    Kondo, Mineo
    Kachi, Shu
    Ito, Yasuki
    Terui, Takayuki
    Ueno, Shinji
    Terasaki, Hiroko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (06): : 1075 - 1082
  • [26] Comparing bevacizumab, ranibizumab, and aflibercept for early reduction of macular edema in patients with retinal vein occlusions (RVO).
    Jansen, Michael Eric
    Tyler, Lyndon
    Kermany, Daniel
    Waters, Jana
    Singer, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] Rebound of Macular Edema After Intravitreal Bevacizumab Therapy in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion
    Yasuda, S.
    Kondo, M.
    Kachi, S.
    Ito, Y.
    Terui, T.
    Terasaki, H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [28] Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion
    Karimi, S.
    Nikkhah, H.
    Nafisi, H.
    Nouri, H.
    Ansari, I.
    Barkhordari, S.
    Samnejad, S.
    Abtahi, S. -H.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (04): : 322 - 326
  • [29] Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Yuan, Alex
    Ahmad, Baseer U.
    Xu, David
    Singh, Rishi P.
    Kaiser, Peter K.
    Martin, Daniel F.
    Sears, Jonathan E.
    Schachat, Andrew P.
    Ehlers, Justis P.
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (01) : 86 - 91
  • [30] Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review
    Yilmaz, Taygan
    Cordero-Coma, Miguel
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (06) : 787 - 793
12345